[EN] BILATERALLY-SUBSTITUTED TRICYCLIC COMPOUNDS FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 (HIV-1) INFECTION AND OTHER DISEASES<br/>[FR] COMPOSÉS TRICYCLIQUES BILATÉRALEMENT SUBSTITUÉS POUR LE TRAITEMENT D'UNE INFECTION AU VIRUS DE L'IMMUNODÉFICIENCE HUMAINE DE TYPE 1 (VIH-1) ET AUTRES MALADIES
申请人:CT DE INVESTIGACIÓN PRÍNCIPE FELIPE
公开号:WO2014128198A1
公开(公告)日:2014-08-28
The invention relates to bilaterally-substituted tricyclic compounds and pharmaceutical compositions containing them, for use as medicaments. Due to their ability to interact with an internal RNA loop and to mimic a protein a-helix these compounds are effective in the treatment and/or prevention of HIV-1 (Human Immunodeficiency Virus-1) infection and other diseases such as those caused by other RNA viruses and by gram-positive and gram-negative bacteria, or infectious or chronic diseases responsive to inhibition of DNA transcription, or infectious or chronic diseases where these compounds can be used to modulate the function of RNA internal loops, or infectious or chronic diseases where these compounds can be used as agonists or inhibitors of a-helical proteins in interaction with other biomolecules.
Synthesis of Supramolecular A
<sub>8</sub>
B
<sub>
<i>n</i>
</sub>
Miktoarm Star Copolymers by Host‐Guest Complexation
作者:Natsumi Nitta、Shin‐ichi Kihara、Takeharu Haino
DOI:10.1002/anie.202219001
日期:2023.3.27
Supramolecular A8Bn (n=1, 2, 4) miktoarmstarcopolymers have been fabricated by host–guest complexation between a resorcinarene-based coordination capsule possessing eight polystyrene chains and 4,4-diacetoxy biphenyl guest molecules with one, two, or four polymethyl acrylate chains. The stability of the A8B1, A8B2, and A8B4 miktoarm polymers was influenced by the number of polymethyl acrylate chains
超分子 A 8 B n ( n =1, 2, 4) miktoarm 星形共聚物是通过主客体络合在具有八个聚苯乙烯链的间苯二酚基配位胶囊和具有一个、两个、两个、或四个聚丙烯酸甲酯链。A 8 B 1、A 8 B 2和A 8 B 4微臂聚合物的稳定性受客体聚合物中聚丙烯酸甲酯链数的影响。
BILATERALLY-SUBSTITUTED TRICYCLIC COMPOUNDS FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 (HIV-1) INFECTION AND OTHER DISEASES